Yahoo Web Search

  1. Press Release ERLEADA (Apalutamide), the First FDA-Approved Treatment for Non-Metastatic, Castration-Resistant Prostate Cancer, Available for Order at Biologics, Inc. Published: Feb 21, 2018 10:00 am ET

  2. Press Release Thomas Jefferson University To Establish The First Education And Training Center For Biologics Manufacturing In North America In Partnership With Global Leader NIBRT Published: Feb 21, 2018 2:30 am ET

  3. The Global Healthy Living Foundation, and its arthritis community, CreakyJoints, which represents millions of people with arthritis, strongly disagrees with last week’s public statement from ...

  4. Press Release Rheumatoid Arthritis Drugs Market Worth $30.4 Billion by 2025: Grand View Research, Inc. Published: Feb 19, 2018 6:15 am ET SAN FRANCISCO, February 19,

  5. CTLT+1.17% the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the addition of three ...

  6. MDXG-0.77% a leading developer and marketer of regenerative and therapeutic biologics, today announced that it will postpone the release of its financial results, as well as the filing ...

  7. If you only made an investing decision based on recent stock performance, Biogen Inc. (NASDAQ:BIIB) would be a hands-down winner over Celgene Corporation (NASDAQ:CELG). Both big biotech stocks ...

  8. Synthetic Biologics, Inc. (NYSEMKT:SYN) Q4 2017 Earnings Conference Call February 22, 2018 08:30 ET Executives Vincent Perrone - Director, Corporate Communicati

  9. Financeswire Protein Expression Market: Global Industry Demand, Size, Growth Report By 2022 Published: Feb 23, 2018 6:49 am ET Feb 23, 2018 (Financeswire via COMTEX) -- Tweet Florida, February 23, 2018:

  10. Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) and Ultragenyx Pharmaceutical Inc. RARE+2.89% today announce that Crysvita (burosumab ...

  1. 12345118 results